NCT02354170: An overdue trial by Roger Goldberg, M.D., MBA
This trial is overdue. It was due to report 6 years, 11 months ago.
Think we've made a mistake? Before contacting us, review the criteria in our paper. In particular, bear in mind the following:
- We can only rely on the structured data that sponsors put into the registry: they may enter incorrect or incomplete data.
- Reporting in a journal is not enough. The FDAAA rules state that the trial must be reported on ClinicalTrials.gov.
- Terminated trials are required to report results. Only withdrawn trials (which never recruited a single patient) are not.
Full data
| Full entry on ClinicalTrials.gov | NCT02354170 |
|---|---|
| Title | Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC) |
| Results Status | Overdue |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 31, 2015 |
| Completion date | April 27, 2017 |
| Required reporting date | April 27, 2018, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 4, 2025 |
| Days late | 2534 |